Fundraising Fox
AI Proteins
Andover, US · Founded 2021 · Delaware corporation · 40 employees on LinkedIn · 3 known investors
Find your way into AI Proteins
Sign up to see every warm intro you have to AI Proteins
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AI Proteins team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AI Proteins designs engineered miniproteins for drug discovery and development in the biopharmaceutical industry. The company uses artificial intelligence to create novel protein-based therapeutics with improved efficacy, safety, and manufacturability compared to naturally evolved proteins.
Founders & leadership
AI Proteins was founded in 2021 by Chris Bahl.
Board
Investors · 3
How we know: Mission Biocapital's portfolio page · funding news · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
Funding
SEC filings, press & company announcements$66.1M disclosed across 4 of 5 rounds · 2022–2025
▶$5MraisedApr 2024 · 8 investors · BiotechnologyRule 506(b)
- Bobby SandageDirector
- Julia A. NovinaExecutive Officer
- Chris BahlExecutive Officer, Director
- Bruce EvansDirector
- Drew DennisonDirector
- Wendy DwyerExecutive Officer
- Todd KaloudisDirector
- Noah BeermanExecutive Officer, Director
- Malcolm SalterDirector
- Offering amount
- $10M
- Amount sold
- $5M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$8.3MraisedAug 2023 · 7 investors · BiotechnologyRule 506(b)
- Noah BeermanExecutive Officer
- Mark AllesDirector
- Malcolm SalterDirector
- Todd KaloudisDirector
- Bobby SandageDirector
- Chris BahlExecutive Officer, Director
- Julia A. NovinaExecutive Officer
- Drew DennisonDirector
- Bruce EvansDirector
- Offering amount
- $10M
- Amount sold
- $8.3M
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$11.3MraisedJan 2022 · 38 investors · BiotechnologyRule 506(b)
- Dominique VerhelleDirector
- Bill McKeeDirector
- Julia NovinaExecutive Officer
- Marc A. CohenExecutive Officer, Director
- Geoff MeyersonDirector
- Elena ProkupetsDirector
- Carl NovinaDirector
- Drew DennisonDirector
- Namandje BumpusDirector
- Arthur BeckerDirector
- Chris BahlExecutive Officer, Director
- Malcolm SalterDirector
- Offering amount
- $18.2M
- Amount sold
- $11.3M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through AI Proteins went on to found or lead other companies.
In the news
Frequently asked questions
- What does AI Proteins do?
- AI Proteins designs engineered miniproteins for drug discovery and development in the biopharmaceutical industry. The company uses artificial intelligence to create novel protein-based therapeutics with improved efficacy, safety, and manufacturability compared to naturally evolved proteins.
- Who founded AI Proteins?
- AI Proteins was founded by Chris Bahl in 2021.
- Who are AI Proteins's investors?
- AI Proteins's investors include Mission Biocapital, Tachyon Ventures, Cobro Ventures.
- How much funding has AI Proteins raised?
- AI Proteins has disclosed $66.1M raised across 4 of its 5 known rounds.
- Where is AI Proteins headquartered?
- AI Proteins is headquartered in Andover, US.